Impact of Vitamin D Levels on Progression-Free Survival and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Systematic Review and Meta-Analysis
Alessandro Ottaiano(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Massimiliano Berretta(University of Messina), Marco Materazzo(Policlinico Tor Vergata), Liliana Montella(Ospedale Santa Maria), Alessia Bignucolo(University of Messina), Gianluca Vanni(Policlinico Tor Vergata), Maria Lucia Iacovino(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Oreste Claudio Buonomo(University of Basilicata), Mariachiara Santorsola(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Vincenzo Quagliariello(Cancer Institute (WIA)), Mario Roselli(University of Rome Tor Vergata), Nicola Maurea(Cancer Institute (WIA)), Giordana Di Mauro(University of Messina), Monica Montopoli(University of Padua), Bianca Arianna Facchini(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Annabella Di Mauro(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Enrica Toscano(University of Messina), Sergio Facchini(Ospedale Santa Maria)
Cited by 8
Related Papers
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Metabolic Plasticity in Chemotherapy Resistance
|Frontiers in Oncology|2020|175
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience
|Cancer Biology & Therapy|2010|108